The Europe Fluoroscopy Market size is estimated at USD 1.38 billion in 2024, and is expected to reach USD 1.66 billion by 2029, growing at a CAGR of 3.73% during the forecast period (2024-2029).
The major factors for the growth of the fluoroscopy devices market in Europe include the rising demand for minimally-invasive surgeries, growing geriatric population, prevalence of chronic diseases, and increasing use of fluoroscopy in pain management.
Medical imaging has applications at various stages in patient management processes, such as diagnosis, staging, therapy delivery, and its follow-ups. The primary role for imaging has been diagnostics, but it is increasing slowly for interventional diagnostics and therapeutic uses that are driven by minimally-invasive procedures. Fluoroscopy presents real-time moving images for diagnostic evaluation of soft and hard tissue conditions. It is an indispensable tool for many interventional medical procedures. The fluoroscopy market is anticipated to register a significant growth, with increasing number of minimally-invasive surgeries that are of high-precision, including the devices used, resulting in better support for both patients and surgeons. The growing preference for minimally-invasive procedures is due to benefits, such as lower risk of complications, reduced cost, and lesser recuperation period, less pain, small incisions, and less scarring, which have contributed to the growth of the market. The use of fluoroscopy in pain management is expected to supplement the growth of the market.
As per European Cardiovascular Disease 2017 Statistics by European Heart Network, over the past two decades, the absolute number of CVD cases has increased in Europe, with increases in the number of new CVD cases found in most countries. In 1990, the incidence of CVD was approximately 4.7 million. However, this number increased to more than 5.4 million by 2015. As the incidence of CVD increases in Europe, the demand for early diagnosis techniques like fluoroscopy is expected to increase. This is expected to help the market in future.
This product will be delivered within 2 business days.
The major factors for the growth of the fluoroscopy devices market in Europe include the rising demand for minimally-invasive surgeries, growing geriatric population, prevalence of chronic diseases, and increasing use of fluoroscopy in pain management.
Medical imaging has applications at various stages in patient management processes, such as diagnosis, staging, therapy delivery, and its follow-ups. The primary role for imaging has been diagnostics, but it is increasing slowly for interventional diagnostics and therapeutic uses that are driven by minimally-invasive procedures. Fluoroscopy presents real-time moving images for diagnostic evaluation of soft and hard tissue conditions. It is an indispensable tool for many interventional medical procedures. The fluoroscopy market is anticipated to register a significant growth, with increasing number of minimally-invasive surgeries that are of high-precision, including the devices used, resulting in better support for both patients and surgeons. The growing preference for minimally-invasive procedures is due to benefits, such as lower risk of complications, reduced cost, and lesser recuperation period, less pain, small incisions, and less scarring, which have contributed to the growth of the market. The use of fluoroscopy in pain management is expected to supplement the growth of the market.
Europe Fluoroscopy Market Trends
Cardiovascular Application is expected to Cover a Large Share of the Market
The early diagnosis of cardiovascular diseases (CVD) has been made possible with the introduction of instruments of precision and advances fluoroscopy. In procedures like cardiac catheterization, fluoroscopy is used to help see the flow of blood through the coronary arteries to check for arterial blockages.As per European Cardiovascular Disease 2017 Statistics by European Heart Network, over the past two decades, the absolute number of CVD cases has increased in Europe, with increases in the number of new CVD cases found in most countries. In 1990, the incidence of CVD was approximately 4.7 million. However, this number increased to more than 5.4 million by 2015. As the incidence of CVD increases in Europe, the demand for early diagnosis techniques like fluoroscopy is expected to increase. This is expected to help the market in future.
Europe Fluoroscopy Industry Overview
European market is competitive players due to the presence of almost all the global players in the fluoroscopy market. Many of these global players have there headquarters in European countries, which increases the accessibility of fluoroscopy devices throughout the Europe.Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Canon Medical Systems Corporation
- Carestream Health
- GE Healthcare
- Hitachi Medical Systems
- Hologic Inc
- Koninklijke Philips NV
- Orthoscan Inc
- Shimadzu Medical
- Siemens Healthineers
- Varian Medical Systems Inc
Methodology
LOADING...
